TP-10 is primarily used in the field of biochemistry and pharmacology as a potent and selective inhibitor of phosphodiesterase 10A (PDE10A). This enzyme plays a significant role in regulating intracellular signaling pathways, particularly in the brain. By inhibiting PDE10A, TP-10 helps in studying the effects of increased cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) levels, which are crucial for understanding various neurological and psychiatric disorders.

In research settings, TP-10 is utilized to explore its potential therapeutic applications in conditions such as schizophrenia, Huntington's disease, and Parkinson's disease. Its ability to modulate neurotransmitter signaling makes it a valuable tool for investigating the pathophysiology of these disorders and for developing new treatment strategies. Additionally, TP-10 is used in preclinical studies to assess its efficacy and safety profile, providing insights into its potential as a drug candidate.